Letters to the Editor

Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD

Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
Department of Radiology, University of British Columbia, Vancouver, BC, Canada
Department of Radiology, University of British Columbia, Vancouver, BC, Canada
Department of Radiology, University of British Columbia, Vancouver, BC, Canada
Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada; Department of Pathology, University of British Columbia, Vancouver, BC, Canada
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada; Department of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
Haematologica Early view Mar 5, 2026 https://doi.org/10.3324/haematol.2025.289285